Bold claim: Americas health systems are upgrading vaccine cold chains now, and the impact goes far beyond storage. But here's where it gets controversial: does expanding equipment always translate into better access for every community? In recent months, 18 countries and territories across the Americas have enhanced their vaccine cold chain systems to preserve potency and strengthen routine immunization. This progress stems from technical cooperation led by the Pan American Health Organization (PAHO) with financial backing from the Government of Canada.
PAHO’s Regional Revolving Funds facilitated Canada’s support, providing roughly 1,000 units of cold chain equipment. The package includes temperature-monitoring devices, long-lasting passive cold boxes and vaccine carriers suited for complex logistics and challenging environments, plus ice-lined refrigerators with freeze-protection technology.
The 18 beneficiaries are Anguilla, Antigua and Barbuda, Bolivia, British Virgin Islands, Cuba, Curaçao, Dominica, Grenada, Haiti, Jamaica, Montserrat, Paraguay, Peru, St. Kitts and Nevis, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, and St. Maarten.
“This new cold chain equipment strengthens a country’s ability to protect every vaccine dose from arrival to the moment it reaches families and communities,” said Santiago Cornejo, Executive Manager of PAHO’s Regional Revolving Funds. “These tools help ensure safety, reduce waste, and expand equitable access to immunization. We are grateful for Canada’s ongoing partnership to bring the latest technologies and innovations to the region.”
The donation is part of a PAHO-implemented project supported by Canada, titled “Improving Equitable Access and Coverage of COVID-19 Vaccination in Latin America and the Caribbean.” The initiative seeks to reinforce public health systems and infrastructure across the region.
PAHO’s Regional Revolving Funds operate as technical cooperation mechanisms that enable American countries to procure quality vaccines, essential medicines, and public health supplies at affordable prices through pooled purchasing and coordinated planning.
Collected results from collective action show substantial savings: about 50 percent on vaccines and other health supplies in the last biennium, benefiting around 180 million people. Over time, the funds have helped countries secure timely access to essential health supplies, supporting progress against HIV/AIDS, malaria, and tuberculosis, while also improving immunization coverage and reducing maternal and child mortality.
If you’re curious about how this translates on the ground, consider this: when cold chain systems work smoothly, vaccination campaigns are less likely to stall, fridges don’t lose potency, and families don’t have to repeat visits because doses were spoiled. Yet debates persist about scope, funding, and the balance between central procurement and local adaptation. What do you think—should international partnerships prioritize rapid equipment upgrades, or focus more on long-term local capacity building and training? Share your thoughts in the comments.
